Quantcast

Latest Imprimis Pharmaceuticals Inc. Stories

2014-06-24 08:30:26

-- Survey highlights interest in easing patient compliance issues associated with conventional post-cataract surgery eye drop regime -- SAN DIEGO, June 24, 2014 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (Nasdaq:IMMY), a vertically-integrated specialty pharmaceutical company dedicated to delivering high quality, novel, and customizable medicines to physicians and patients at accessible prices, today unveiled the results of a recent survey(1) of leading national cataract surgeons...

2014-05-28 08:31:20

-- Imprimis' proprietary ophthalmic compounded formulations now available in 25 states and territories with a physician's prescription -- SAN DIEGO, May 28, 2014 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (Nasdaq: IMMY), a vertically-integrated specialty pharmaceutical company dedicated to delivering high quality, novel, and customizable medicines to physicians and patients at accessible prices, announced today its attendance at the upcoming 2014 Kiawah Eye Meeting...

2014-04-22 08:33:03

- Imprimis' ophthalmic formulations now commercially available with a physician's prescription - SAN DIEGO, April 22, 2014 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (Nasdaq: IMMY), a vertically-integrated specialty pharmaceutical company focused on the development and commercialization of proprietary sterile and topical compounded drug formulations, announced today its attendance and physicians' presentations at the upcoming American Society of Cataract and Refractive Surgery (ASCRS)...

2014-03-25 08:28:42

--Company presentation will be webcast/available at www.imprimispharma.com-- SAN DIEGO, March 25, 2014 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (Nasdaq: IMMY), a specialty pharmaceutical company focused on the development and commercialization of proprietary sterile and topical drug formulations, today announced that Imprimis CEO Mark L. Baum is scheduled to present at the 13(th) Annual Needham Healthcare Conference in New York City on Wednesday, April 9, 2014, at 3:40 p.m. ET....

2014-03-04 08:30:54

Company presentation will be webcast/available at www.imprimispharma.com SAN DIEGO, March 4, 2014 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (Nasdaq: IMMY), a specialty pharmaceutical company focused on the development and commercialization of proprietary sterile and topical drug formulations, today announced that Imprimis CEO Mark L. Baum is scheduled to participate at two growth investor conferences during the month of March. On Monday, March 10, 2014, Mr. Baum is...

2014-02-25 08:30:30

--First-time cataract formulation clinical data and clinical experience will be presented at a U.S. ophthalmic meeting -- SAN DIEGO, Feb. 25, 2014 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (Nasdaq: IMMY), a specialty pharmaceutical company focused on the development and commercialization of proprietary sterile and topical drug formulations, today announced that James Lewis, MD (http://cataractphiladelphia.com), will present "Dropless Cataract Surgery" during the New Technologies...

2014-02-19 08:29:46

- House to lead company's distribution strategy and pharmacy operations efforts to make and distribute Imprimis' patent-pending formulations - SAN DIEGO, Feb. 19, 2014 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (Nasdaq: IMMY), a specialty pharmaceutical company focused on the development and commercialization of proprietary and novel sterile and topical drug formulations, today announced that Randle House has joined the company as Vice President of Pharmacy Operations. In this...

2014-02-11 08:30:29

-- Transaction marks important milestone as company approaches commercial launch targeting ophthalmologists -- SAN DIEGO, Feb. 11, 2014 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (Nasdaq: IMMY), a specialty pharmaceutical company focused on the development and commercialization of proprietary and novel sterile and topical drug formulations, today announced that it has come to an agreement to acquire Pharmacy Creations LLC (www.pharmacycreations.com), a premier, state-of-the-art...

2014-01-28 08:29:07

-Company Continues Go Dropless(TM) Information Campaign Targeted at Ophthalmologists- SAN DIEGO, Jan. 28, 2014 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (NASDAQ:IMMY), a specialty pharmaceutical company focused on the development and commercialization of proprietary sterile and topical drug formulations, today announced that it will be attending the ACES/SEE Caribbean Eye Meeting (http://caribbeaneyemeeting.com/) in Cancun, Mexico, January 31 to February 4, 2014. Imprimis will...


Word of the Day
penuche
  • A fudgelike confection of brown sugar, cream or milk, and chopped nuts.
'Penuche' is a variant of 'panocha,' a coarse grade of sugar made in Mexico. 'Panocha' probably comes from the Spanish 'panoja, panocha,' ear of grain.
Related